Real-world treatment patterns and outcomes in ER+/PR+/HER2+metastatic breast cancer (MBC) patients: A National Cancer Database analysis.

被引：2
|
作者：
Statler, Abby
Nahleh, Zeina A.
Hobbs, Brian
Wei, Wei
Gupta, Annie
Blake, Cassann N.
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[2] Cleveland Clin Florida, El Paso, TX USA
[3] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA
[4] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[5] Cleveland Clin Florida, Weston, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.1033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1033
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Is capecitabine (CAPE) the best treatment (trt) option for estrogen receptor-positive (ER+) HER2-negative (HER2-) metastatic breast cancer (MBC) after progression on endocrine treatment (ET): An analysis of the ESME real-world database
    Pflumio, C.
    Carton, M.
    Debled, M.
    Cottu, P. H.
    Leheurteur, M.
    Dalenc, F.
    Jacot, W.
    Mailliez, A.
    Sauterey, B.
    Levy, C.
    Kaderbhai, C.
    Tredan, O.
    Goncalves, A.
    Uwer, L.
    Robert, M.
    Bailleux, C.
    Cabel, L.
    Delaloge, S.
    Bosquet, L.
    Petit, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S374 - S375
  • [42] PRELIMINARY DATA FROM A PROSPECTIVE NON-INTERVENTIONAL STUDY TO CHARACTERIZE REAL-WORLD TREATMENT PATTERNS AND OUTCOMES OF WOMEN WITH ER+/HER2-ADVANCED/METASTATIC BREAST CANCER
    Cazzaniga, Marina Elena
    Cagossi, Katia
    Valerio, Maria Rosaria
    Russo, Salvatore
    Casadei, Virginia
    Scognamiglio, Giovanni
    Cavanna, Luigi
    Toniolo, Davide
    Deconciliis, Erico Maria Romani
    Melegari, Elisabetta
    Stocchi, Lucia
    Gebbia, Vittorio
    Vandone, Anna Maria
    Cursano, Maria Concetta
    Pinotti, Graziella
    Rossello, Rosalba
    Ortu, Salvatorico
    Pellegrino, Benedetta
    Saracchini, Silvana
    Pedroli, Stefania
    Torri, Valter
    BREAST, 2017, 36 : S48 - S49
  • [43] PRELIMINARY DATA FROM A PROSPECTIVE NON-INTERVENTIONAL STUDY TO CHARACTERIZE REAL-WORLD TREATMENT PATTERNS AND OUTCOMES OF WOMEN WITH ER+/HER2-ADVANCED/METASTATIC BREAST CANCER
    Harbeck, Nadia
    De laurentiis, Michele
    Mitra, Debanjali
    Trantham, Laurel
    Di Virgilio, Roberto
    De Placido, Sabino
    BREAST, 2017, 36 : S48 - S48
  • [44] Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis
    Patt, Debra
    Liu, Xianchen
    Li, Benjamin
    McRoy, Lynn
    Layman, Rachel M.
    Brufsky, Adam
    CLINICAL BREAST CANCER, 2022, 22 (06) : 601 - 610
  • [45] Real-world outcomes and safety of pyrotinib in HER2-positive metastatic breast cancer (MBC) patients: A prospective cohort study
    Luo, T.
    Zhang, Q.
    He, P.
    Zhong, X.
    Yan, X.
    Tian, T.
    Huang, J.
    Zhang, Z.
    Zheng, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S490 - S490
  • [46] Real-world use and outcomes of trastuzumab for HER2+metastatic breast cancer in Australia: Analysis of the herceptin program, 2001-2015
    Daniels, Benjamin
    Kiely, Belinda E.
    Lord, Sarah J.
    Houssami, Nehmat
    Pearson, Sallie-Anne
    CANCER RESEARCH, 2018, 78 (04)
  • [47] Serum HER-2 ECD and the efficacy of letrozole in ER+/PR+ metastatic breast cancer: preliminary results of a prospective study.
    Colomer, R
    Llombart, A
    Ramos, M
    Mayordomo, JI
    Fernandez, R
    Tusquets, I
    Barnadas, A
    Gil, M
    Carabantes, F
    Baena, JM
    Ruiz, M
    Palomero, M
    Vera, R
    Munoz, M
    Constenla, M
    Rifa, J
    Ojeda, B
    Calvo, L
    Lloveras, B
    Montero, S
    Alba, E
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 242 - 242
  • [48] Real-world PARPi treatment patterns and outcomes among patients with metastatic breast cancer.
    Dawood, Shaheenah S.
    Brzozowski, Kaylen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] Real-world treatment in patients with HER2+ metastatic breast cancerTreatment decisions in HER2+ mBC
    R. Colomer
    P. Hall
    M. Szkultecka-Debek
    R. C. Bondi
    A. Flinois
    S. Auziere
    J. Y. Le Cléac’h
    Breast Cancer Research and Treatment, 2018, 168 : 197 - 205
  • [50] A real-world registry to evaluate HER2-directed therapy in Australian patients with metastatic breast cancer (MBC).
    Lee, Margaret
    Lok, Sheau Wen
    Turner, Natalie Heather
    Day, Daphne
    Greenberg, Sally
    Green, Michael
    Foo, Serene S.
    Yip, Desmond
    Nott, Louise M.
    Gibbs, Peter
    De Boer, Richard H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345